References
- Favaloro EJ, Thom J, Patterson D, , et al. Desmopressin therapy to assist the functional identification and characterisation of von Willebrand disease: Differential utility from combining two (VWF:CB and VWF:RCo) von Willebrand factor activity assays? Thromb Res 2008; Dec 7: (Epub ahead of print).
- Favaloro EJ Semin Thromb Hemost 2009; 35: (in press).
- Webert KE, Cserti CM, Hannon J, Lin Y, Pavenski K, Pendergrast JM, Blajchman MA. Proceedings of a Consenus Conference: pathogen inactivation – making decisions about new technologies. Transfus Med Rev 2008; 22: 1–34
- Favaloro EJ, Bonar R. Emerging technologies and quality assurance in hemostasis: a review of findings from the Royal College of Pathologists of Australasia Quality Assurance Program. Semin Thromb Hemost 2007; 33: 235–42